-
1دورية أكاديمية
المصدر: Blood [Blood] 2024 Jul 18; Vol. 144 (3), pp. 341.
نوع المنشور: Letter; Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
مواضيع طبية MeSH: Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology , Hodgkin Disease*/blood , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage, Humans ; Follow-Up Studies ; Antineoplastic Agents, Immunological/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Female ; Male
-
2دورية أكاديمية
المؤلفون: Yan C; University of Alabama at Birmingham, Birmingham, AL., Richard MA; Baylor College of Medicine, Houston, TX., Gibson CJ; Dana Farber Cancer Institute, Boston, MA., He J; University of Alabama at Birmingham, Birmingham, AL., Bosworth A; City of Hope, Duarte, CA., Crossman DK; University of Alabama at Birmingham, Birmingham, AL., Singh P; University of Alabama at Birmingham, Birmingham, AL., Hageman L; University of Alabama at Birmingham, Birmingham, AL., Kalra R; University of Alabama at Birmingham, Birmingham, AL., Armenian SH; City of Hope, Duarte, CA., Vose J; University of Nebraska, Omaha, NE., Weisdorf DJ; University of Minnesota, Minneapolis, MN., Ebert BL; Dana Farber Cancer Institute, Boston, MA., Yasui Y; St Jude Children's Research Hospital, Memphis, TN., Forman SJ; City of Hope, Duarte, CA., Bhatia R; University of Alabama at Birmingham, Birmingham, AL., Bhatia S; University of Alabama at Birmingham, Birmingham, AL.
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 10; Vol. 42 (20), pp. 2415-2424. Date of Electronic Publication: 2024 Apr 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Hodgkin Disease*/therapy , Hodgkin Disease*/genetics , Transplantation, Autologous*/adverse effects , Clonal Hematopoiesis*/genetics , Neoplasms, Second Primary*/genetics , Neoplasms, Second Primary*/etiology , Mutation*, Humans ; Adult ; Female ; Male ; Middle Aged ; Retrospective Studies ; Adolescent ; Young Adult ; Aged ; Peripheral Blood Stem Cell Transplantation/adverse effects ; Tumor Suppressor Protein p53/genetics ; DNA Methyltransferase 3A ; Protein Phosphatase 2C/genetics ; DNA (Cytosine-5-)-Methyltransferases/genetics ; Dioxygenases ; DNA-Binding Proteins/genetics ; Proto-Oncogene Proteins/genetics
-
3دورية أكاديمية
المؤلفون: Pangaribuan FD; Anatomical Pathology Department, Persahabatan Hospital, Jakarta, 13230, Indonesia., Ham MF; Anatomical Pathology Department, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, 10430, Indonesia.; Faculty of Medicine Universitas Indonesia, Human Cancer Research Center-Indonesian Medical Education and Research Institute, Jakarta, 10430, Indonesia., Mutmainnah M; Faculty of Medicine, Universitas Muhammadiyah Palembang, Palembang, 30263, Indonesia., Harahap AS; Anatomical Pathology Department, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, 10430, Indonesia. agnes.stephanie01@ui.ac.id.; Faculty of Medicine Universitas Indonesia, Human Cancer Research Center-Indonesian Medical Education and Research Institute, Jakarta, 10430, Indonesia. agnes.stephanie01@ui.ac.id.
المصدر: BMC research notes [BMC Res Notes] 2024 Jul 08; Vol. 17 (1), pp. 190. Date of Electronic Publication: 2024 Jul 08.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500 (Electronic) Linking ISSN: 17560500 NLM ISO Abbreviation: BMC Res Notes Subsets: MEDLINE
مواضيع طبية MeSH: Hodgkin Disease*/pathology , Hodgkin Disease*/metabolism , Hodgkin Disease*/immunology , Hodgkin Disease*/genetics , CTLA-4 Antigen*/metabolism , CTLA-4 Antigen*/genetics, Humans ; Male ; Female ; Prognosis ; Adult ; Middle Aged ; Young Adult ; Adolescent ; Neoplasm Staging ; Aged ; Biomarkers, Tumor/metabolism
-
4دورية أكاديمية
المؤلفون: Mbai MM; Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania. mutheumbai@gmail.com.; Department of Oncology, Longisa County Referral Hospital, Bomet, Kenya. mutheumbai@gmail.com., Mduma E; Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.; Department of Clinical Oncology, Rabininsia Memorial Hospital, Dar Es Salaam, Tanzania., Thuo S; Department of Otolaryngology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Rugengamanzi E; Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.; Butaro Cancer Center of Excellence, Burera, Rwanda.; School of Medicine, University of Global Health Equity, Kigali, Rwanda., Malichewe CV; Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Lugina EL; Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.; Academic, Research and Consultancy Unit, Ocean Road Cancer Institute, Dar Es Salaam, Tanzania.
المصدر: BMC cancer [BMC Cancer] 2024 Jul 03; Vol. 24 (1), pp. 796. Date of Electronic Publication: 2024 Jul 03.
نوع المنشور: Journal Article; Comparative Study
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Hodgkin Disease*/epidemiology , Hodgkin Disease*/drug therapy , Hodgkin Disease*/mortality , HIV Infections*/drug therapy , HIV Infections*/complications , HIV Infections*/epidemiology , Antiretroviral Therapy, Highly Active*, Humans ; Tanzania/epidemiology ; Male ; Female ; Adult ; Retrospective Studies ; Middle Aged ; Treatment Outcome ; Young Adult ; Adolescent
-
5دورية أكاديمية
المؤلفون: Velasco-Suelto J; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain., Gálvez-Carvajal L; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain., Comino-Méndez I; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain. inaki.comino@ibima.eu.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain. inaki.comino@ibima.eu.; Andalusia-Roche Network in Precision Medical Oncology, 41092, Seville, Spain. inaki.comino@ibima.eu.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16, 12/00481); 28029, Madrid, Spain. inaki.comino@ibima.eu.; Clinical and Translational Cancer Research Group, IBIMA Institute, C/ Severo Ochoa, ParqueTecnologico de Andalucia (PTA), 35, 29590, Campanillas-Malaga, Spain. inaki.comino@ibima.eu., Rueda-Domínguez A; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Andalusia-Roche Network in Precision Medical Oncology, 41092, Seville, Spain.
المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jul 02; Vol. 43 (1), pp. 184. Date of Electronic Publication: 2024 Jul 02.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Hodgkin Disease*/genetics , Hodgkin Disease*/diagnosis , Hodgkin Disease*/pathology, Humans ; Liquid Biopsy/methods ; Circulating Tumor DNA/genetics ; Biomarkers, Tumor
-
6دورية أكاديمية
المؤلفون: Gonzalez-Kozlova E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Huang HH; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Jagede OA; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tuballes K; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Del Valle DM; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Kelly G; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Patel M; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Xie H; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Harris J; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Argueta K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Nie K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Barcessat V; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Moravec R; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Altreuter J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kahl BS; Washington University School of Medicine, New York, New York., Ansell SM; Mayo Clinic, New York, New York., Yu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Cerami E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Lindsay JR; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kim-Schulze S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Diefenbach CS; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Gnjatic S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York.
المصدر: Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1726-1737.
نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
مواضيع طبية MeSH: Brentuximab Vedotin*/therapeutic use , Hodgkin Disease*/drug therapy , Hodgkin Disease*/immunology , Hodgkin Disease*/blood , Nivolumab*/therapeutic use , Nivolumab*/administration & dosage , Ipilimumab*/therapeutic use , Ipilimumab*/administration & dosage , Ipilimumab*/pharmacology , Drug Resistance, Neoplasm* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Male ; Adult ; Middle Aged ; Aged ; Young Adult
-
7تقرير
المؤلفون: Alma A; Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.; PhD Course in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy., Fiorito F; Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy., Casari A; Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy., Ciardo S; Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy., Lancellotti C; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy., Maccaferri M; Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena and Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Farnetani F; Dermatology Unit, Department of Surgical, Medical, Dental and Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
المصدر: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Jul; Vol. 30 (7), pp. e13836.
نوع المنشور: Case Reports; Letter
بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 9504453 Publication Model: Print Cited Medium: Internet ISSN: 1600-0846 (Electronic) Linking ISSN: 0909752X NLM ISO Abbreviation: Skin Res Technol Subsets: MEDLINE
مواضيع طبية MeSH: Dermoscopy*/methods , Hodgkin Disease*/diagnostic imaging , Hodgkin Disease*/pathology , Microscopy, Confocal*/methods , Skin Neoplasms*/pathology , Skin Neoplasms*/diagnostic imaging, Humans ; Male ; Female ; Adult
-
8دورية أكاديمية
المؤلفون: Binkley MS; Department of Radiation Oncology, Stanford School of Medicine, Stanford University, Stanford, CA., Flerlage JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN., Savage KJ; BC Cancer, Vancouver, Canada., Akhtar S; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Steiner R; The University of Texas MD Anderson Cancer Center, Houston, TX., Zhang XY; Oxford University, Oxford, United Kingdom., Dickinson M; Peter MacCallum Cancer Centre, Melbourne, Australia., Prica A; Princess Margaret Cancer Centre, Toronto, Canada., Major A; The University of Chicago, Chicago, IL., Hendrickson PG; Duke University, Durham, NC., Hopkins D; Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Ng A; Dana-Farber Cancer Institute, Boston, MA., Casulo C; University of Rochester, Rochester, NY., Baron J; University of Pennsylvania, Philadelphia, PA., Roberts KB; Yale University, New Haven, CT., Al Kendi J; The Royal Hospital, Muscat, Oman., Balogh A; Tom Baker Cancer Centre, Calgary, Canada., Ricardi U; Department of Oncology, University of Turin, Turin, Italy., Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Specht L; Copenhagen University Hospital, Copenhagen, Denmark., De Silva R; Norfolk and Norwich University Hospital, Norfolk, United Kingdom., Pickard K; Newcastle upon Tyne Hospitals, Newcastle upon Tyne, United Kingdom., Blazin LJ; Division of Hematology/Oncology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN., Henry M; Phoenix Children's Hospital, Phoenix, AZ., Smith CM; Vanderbilt University Medical Center, Nashville, TN., Halperin D; University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Brady J; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Brennan B; Manchester University NHS Foundation Trust, Manchester, United Kingdom., Senchenko MA; Oncology and Immunology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Moscow, Russian Federation., Reeves M; Royal Manchester Children's Hospital, Manchester, United Kingdom., Hoppe BS; University of Florida, Gainesville, FL.; Mayo Clinic, Jacksonville, FL., Terezakis S; Johns Hopkins University, Baltimore, MD., Talaulikar D; Canberra Health Services, Canberra, Australia.; College of Health and Medicine, Australian National University, Canberra, Australia., Picardi M; Department of Clinical Medicine and Surgery, AOU Federico II, Naples, Italy., Kirova Y; Institute Curie, Paris, France., Fergusson P; Birmingham Children's Hospital, Birmingham, United Kingdom., Hawkes EA; Olivia Newton-John Cancer Research Centre at Austin Health, Melbourne, Australia.; Lymphoma and Related Diseases Registry, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Lee D; Austin Hospital, Eastern Health, Melbourne, Australia., Doo NW; Lymphoma and Related Diseases Registry, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Haematology, Concord Hospital, Concord Clinical School, University of Sydney, Sydney, Australia., Barraclough A; Department of Haematology, Fiona Stanley Hospital, Perth, Australia., Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia., Ku M; Department of Haematology, St Vincent's Hospital, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Hamad N; Department of Haematology, St Vincent's Hospital Sydney, Sydney, Australia.; Faculty of Medicine and Health, School of Clinical Medicine, UNSW Sydney, Sydney, Australia.; School of Medicine, University of Notre Dame, Sydney, Australia., Mutsando H; Faculty of Medicine and Health, School of Clinical Medicine, UNSW Sydney, Sydney, Australia.; University of Queensland Rural Clinical School, Toowoomba, Australia., Gilbertson M; Monash University, Melbourne, Australia., Marconi T; Eastern Health, Melbourne, Australia., Viiala N; Department of Haematology, Liverpool Hospital, Liverpool, Australia.; South West Sydney Clinical School, UNSW Medicine, Liverpool, Australia., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Eichenauer DA; Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University Hospital Cologne, German Hodgkin Study Group, Cologne, Germany., Hoppe RT; Department of Radiation Oncology, Stanford School of Medicine, Stanford University, Stanford, CA.
مؤلفون مشاركون: GLOW Consortium
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 01; Vol. 42 (19), pp. 2271-2280. Date of Electronic Publication: 2024 Mar 26.
نوع المنشور: Journal Article; Multicenter Study
بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Hodgkin Disease*/therapy , Hodgkin Disease*/pathology , Hodgkin Disease*/mortality, Humans ; Male ; Adult ; Female ; Middle Aged ; Retrospective Studies ; Young Adult ; Prognosis ; Progression-Free Survival ; Neoplasm Staging
-
9دورية أكاديمية
المؤلفون: Knaup H; Department of Nuclear Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany (H.K., J.W., L.V.H., C.A.V., M.D., C.K., K.R.)., Weindler J; Department of Nuclear Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany (H.K., J.W., L.V.H., C.A.V., M.D., C.K., K.R.)., van Heek L; Department of Nuclear Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany (H.K., J.W., L.V.H., C.A.V., M.D., C.K., K.R.)., Voltin CA; Department of Nuclear Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany (H.K., J.W., L.V.H., C.A.V., M.D., C.K., K.R.)., Fuchs M; German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Cologne Bonn, University Hospital of Cologne, Cologne, Germany (M.F., P.B.)., Borchmann P; German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Cologne Bonn, University Hospital of Cologne, Cologne, Germany (M.F., P.B.)., Dietlein M; Department of Nuclear Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany (H.K., J.W., L.V.H., C.A.V., M.D., C.K., K.R.)., Kobe C; Department of Nuclear Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany (H.K., J.W., L.V.H., C.A.V., M.D., C.K., K.R.). Electronic address: carsten.kobe@uk-koeln.de., Roth K; Department of Nuclear Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany (H.K., J.W., L.V.H., C.A.V., M.D., C.K., K.R.).
المصدر: Academic radiology [Acad Radiol] 2024 Jul; Vol. 31 (7), pp. 3020-3025. Date of Electronic Publication: 2023 Dec 27.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Association Of University Radiologists Country of Publication: United States NLM ID: 9440159 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4046 (Electronic) Linking ISSN: 10766332 NLM ISO Abbreviation: Acad Radiol Subsets: MEDLINE
مواضيع طبية MeSH: Positron Emission Tomography Computed Tomography*/methods , Tumor Burden* , Fluorodeoxyglucose F18*/pharmacokinetics , Radiopharmaceuticals*/pharmacokinetics , Hodgkin Disease*/diagnostic imaging , Hodgkin Disease*/metabolism , Hodgkin Disease*/pathology, Humans ; Male ; Female ; Middle Aged ; Adult ; Aged ; Young Adult ; Adolescent
-
10دورية أكاديمية
المؤلفون: Wang R; From the Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University., Cai H; From the Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University., Liu C; Department of Nuclear Medicine, Shanghai First People Hospital, Jiao Tong University School of Medicine, Shanghai, China., Lv Z; From the Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University., Ma C; From the Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University.
المصدر: Clinical nuclear medicine [Clin Nucl Med] 2024 Jul 01; Vol. 49 (7), pp. 650-651. Date of Electronic Publication: 2024 May 01.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE
مواضيع طبية MeSH: Fluorodeoxyglucose F18* , Positron Emission Tomography Computed Tomography* , Hodgkin Disease*/diagnostic imaging , Hodgkin Disease*/pathology , Thyroid Cancer, Papillary*/diagnostic imaging , Thyroid Cancer, Papillary*/pathology , Thyroid Neoplasms*/diagnostic imaging , Thyroid Neoplasms*/pathology, Humans ; Female ; Middle Aged ; Carcinoma, Papillary/diagnostic imaging ; Carcinoma, Papillary/pathology ; Adult